Published in Hepatitis Weekly, August 21st, 2006
Study 1: According to recent research from the People's Republic of China, estrogen receptor (ER) alpha polymorphisms are associated with susceptibility to hepatocellular carcinoma (HCC) in hepatitis B virus carriers.
"Overexpression of ESRs is implicated in the development of HCC in both animal models and humans. We examined whether the ESR1 polymorphisms were related to HCC risk among chronic hepatitis B virus carriers," wrote Y. Zhai and colleagues, Beijing Institute of Radiation Medicine.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.